Literature DB >> 25877652

Unified-planning, graded-administration, and centralized-controlling: a management modality for treating acquired immune deficiency syndrome with Chinese medicine in Henan Province of China.

Li-Ran Xu1, Hui-jun Guo, Zhi-bin Liu, Qiang Li, Ji-ping Yang, Ying He.   

Abstract

Henan Province in China has a major epidemic of human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS). Chinese medicine (CM) has been used throughout the last decade, and a management modality was developed, which can be described by unified-planning, graded-administration, and centralized-controlling (UGC). The UGC modality has one primary concept (patient-centered medicine from CM theory), four basic foundations (classifying administrative region, characteristics of CM on disease treatment, health resource conditions, and distribution of patients living with HIV), six important relationships (the "three uniformities and three combinations," and the six relationships therein guide the treatment of AIDS with CM), and four key sections (management, operation, records, and evaluation). In this article, the authors introduce the UGC modality, which could be beneficial to developing countries or resource-limited areas for the management of chronic infectious disease.

Entities:  

Mesh:

Year:  2015        PMID: 25877652      PMCID: PMC7089398          DOI: 10.1007/s11655-015-2138-x

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  10 in total

1.  AIDS--the first 20 years.

Authors:  K A Sepkowitz
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

2.  Factors associated with fatigue in acquired immunodeficiency syndrome patients with antiretroviral drug adverse reactions: a retrospective study.

Authors:  Zhibin Liu; Jiping Yang; Huijuan Liu; Yantao Jin
Journal:  J Tradit Chin Med       Date:  2013-06       Impact factor: 0.848

Review 3.  Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence.

Authors:  Ming-Ming Zhang; Xue-Mei Liu; Lin He
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

4.  HIV-1 infection in commercial plasma donors in China.

Authors:  Z Wu; Z Liu; R Detels
Journal:  Lancet       Date:  1995-07-01       Impact factor: 79.321

5.  Survival of people living with HIV after treatment with traditional Chinese medicine in Henan province of China: a retrospective cohort study.

Authors:  Yantao Jin; Zhibin Liu; Xiumin Chen; Xin Wang; Dan Wang; Ziqiang Jiang; Ying Liu; Jian Wang; Wen Zou; Huijun Guo; Liran Xu
Journal:  J Tradit Chin Med       Date:  2014-08       Impact factor: 0.848

6.  Effects of the Ganning formula on liver fibrosis in patients with chronic hepatitis B.

Authors:  Xin Deng; Jian Liang; Fa-Sheng Wu; Yan-Bo Li; Yan-Fang Tang
Journal:  J Tradit Chin Med       Date:  2011-12       Impact factor: 0.848

7.  Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.

Authors:  Chen Wang; Bin Cao; Qing-Quan Liu; Zhi-Qiang Zou; Zong-An Liang; Li Gu; Jian-Ping Dong; Li-Rong Liang; Xing-Wang Li; Ke Hu; Xue-Song He; Yan-Hua Sun; Yu An; Ting Yang; Zhi-Xin Cao; Yan-Mei Guo; Xian-Min Wen; Yu-Guang Wang; Ya-Ling Liu; Liang-Duo Jiang
Journal:  Ann Intern Med       Date:  2011-08-16       Impact factor: 25.391

Review 8.  Treatment of acquired immunodeficiency syndrome with Chinese medicine in China: opportunity, advancement and challenges.

Authors:  Zhi-Bin Liu; Xin Wang; Hui-Juan Liu; Yan-Tao Jin; Hui-Jun Guo; Zi-Qiang Jiang; Zhen Li; Li-Ran Xu
Journal:  Chin J Integr Med       Date:  2013-07-29       Impact factor: 1.978

9.  Reliability and validity of dermatology life quality index: assessment of quality of life in human immunodeficiency virus/acquired immunodeficiency syndrome patients with pruritic papular eruption.

Authors:  Zhibin Liu; Zheng Xie; Li Zhang; Yantao Jin; Huijun Guo; Ziqiang Jiang; Xiumin Chen; Jun Yuan
Journal:  J Tradit Chin Med       Date:  2013-10       Impact factor: 0.848

10.  High prevalence of HIV infection among women and their children in Henan Province, China.

Authors:  Ke Zhuang; Xien Gui; Bo Su; Po Tien; Zhiwei Chen; Linqi Zhang
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-15       Impact factor: 3.731

  10 in total
  6 in total

1.  Advantages of Chinese Medicine for Patients with Acquired Immunodeficiency Syndrome in Rural Central China.

Authors:  Qian-Lei Xu; Hui-Jun Guo; Yan-Tao Jin; Jian Wang; Zi-Qiang Jiang; Zheng-Wei Li; Xiu-Min Chen; Ying Liu; Li-Ran Xu
Journal:  Chin J Integr Med       Date:  2017-09-08       Impact factor: 1.978

Review 2.  Effectiveness and safety of traditional Chinese medicine in treating acquired immune deficiency syndrome: 2004-2014.

Authors:  Zhi-Bin Liu; Ji-Ping Yang; Li-Ran Xu
Journal:  Infect Dis Poverty       Date:  2015-12-23       Impact factor: 4.520

3.  Treating older patients with AIDS using Traditional Chinese Medicine Combined with Conventional Western Medicine in China.

Authors:  Zhibin Liu
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

4.  Effects of Chinese Medicine on the Survival of AIDS Patients Administered Second-Line ART in Rural Areas of China: A Retrospective Cohort Study Based on Real-World Data.

Authors:  Yantao Jin; Miao Zhang; Yanmin Ma; Feng Sang; Pengyu Li; Chunling Yang; Dongli Wang; Huijun Guo; Zhibin Liu; Qianlei Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-27       Impact factor: 2.629

5.  Study on the Mechanism of Improving HIV/AIDS Immune Function with Jian Aikang Concentrated Pill Based on Network Pharmacology Combined with Experimental Validation.

Authors:  Cancan Shao; Haojie Wang; Feng Sang; Liran Xu
Journal:  Drug Des Devel Ther       Date:  2022-08-18       Impact factor: 4.319

6.  Effect of Traditional Chinese Medicine Therapy on the Trend in CD4+ T-Cell Counts among Patients with HIV/AIDS Treated with Antiretroviral Therapy: A Retrospective Cohort Study.

Authors:  Dongli Wang; Suna Ma; Yanmin Ma; Huijun Guo; Pengyu Li; Chunling Yang; Qianlei Xu; Zhibin Liu; Yantao Jin
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-15       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.